These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2645432)

  • 21. Uric acid and its relationship with glycosaminoglycans in normal and stone-former subjects.
    Conte A; Roca P; Genestar C; Grases F
    Nephron; 1989; 52(2):162-5. PubMed ID: 2500615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Etiopathogenesis, clinical manifestations, and management of canine calcium oxalate urolithiasis.
    Osborne CA; Poffenbarger EM; Klausner JS; Johnston SD; Griffith DP
    Vet Clin North Am Small Anim Pract; 1986 Jan; 16(1):133-70. PubMed ID: 3518199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Urinary calculus protective side effects of anti-rheumatic therapy].
    Schlichter A; Brundig P
    Z Urol Nephrol; 1990 Apr; 83(4):175-81. PubMed ID: 2378178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of ethyl icosapentate on urinary calcium excretion in calcium oxalate stone formers.
    Ito H; Kotake T; Nomura K
    Urol Int; 1995; 54(4):208-13. PubMed ID: 7610503
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical study on recurrence of urinary tract lithiasis of ESWL].
    Kato S; Ujiie T; Mori K; Nakajima H; Ohnishi S; Tanda H
    Nihon Hinyokika Gakkai Zasshi; 1990 Feb; 81(2):178-81. PubMed ID: 2325313
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Placebo versus allopurinol for recurrent urinary calculi.
    Smith MJ
    Proc Eur Dial Transplant Assoc; 1983; 20():422-6. PubMed ID: 6361753
    [No Abstract]   [Full Text] [Related]  

  • 27. [Value of diurnal variations of urinary pH for the determination of the chemical composition of urinary calculi].
    Serniak PS; Bilobrov VM; Litvinenko LM; Minas'iants EZ; Chugaĭ AV
    Urol Nefrol (Mosk); 1984; (3):21-6. PubMed ID: 6539972
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of dietary control of urinary uric acid excretion in calcium oxalate stone formers and non-stone-forming controls.
    Pais VM; Holmes RP; Assimos DG
    J Endourol; 2007 Feb; 21(2):232-5. PubMed ID: 17338626
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of allopurinol on urinary oxalate excretion in stone formers.
    Scott R; Paterson PJ; Mathieson A; Smith M
    Br J Urol; 1978 Dec; 50(7):455-8. PubMed ID: 753494
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urate and calcium oxalate stones: from repute to rhetoric to reality.
    Grover PK; Ryall RL
    Miner Electrolyte Metab; 1994; 20(6):361-70. PubMed ID: 7783698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in urinary composition of calcium oxalate stone formers.
    Rahman B; Rahman MA
    Biomed Pharmacother; 1986; 40(3):108-10. PubMed ID: 3742009
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A study of crystalluria in calcium oxalate stone patients treated with thiazides.
    Daudon M; Jungers P; Reveillaud RJ
    Contrib Nephrol; 1987; 58():78-81. PubMed ID: 3691151
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical results of allopurinol treatment in prevention of calcium oxalate stone formation.
    Tiselius HG; Larsson L; Hellgren E
    J Urol; 1986 Jul; 136(1):50-3. PubMed ID: 3712614
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simple classification of renal calculi closely related to their micromorphology and etiology.
    Grases F; Costa-Bauzá A; Ramis M; Montesinos V; Conte A
    Clin Chim Acta; 2002 Aug; 322(1-2):29-36. PubMed ID: 12104078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Change in inhibitory potential in urine of hyperuricosuric calcium oxalate stone formers effected by allopurinol and orthophosphates.
    Goldwasser B; Sarig S; Azoury R; Wax Y; Hirsch D; Perlberg S; Many M
    J Urol; 1984 Nov; 132(5):1008-11. PubMed ID: 6492268
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Uric acid and oxalate lithiasis. Physico-chemical and crystallo-chemical explanation of the relationship].
    Leskovar P
    Z Urol Nephrol; 1980 Mar; 73(3):211-21. PubMed ID: 7434985
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The influence of uric acid on the calcium oxalate stone formation (author's transl)].
    Matouschek E; Huber R
    Urologe A; 1979 Jul; 18(4):211-4. PubMed ID: 38552
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Allopurinol for the prevention of calcium oxalate calculi.
    Ulmann A
    N Engl J Med; 1987 May; 316(22):1415-6. PubMed ID: 3574420
    [No Abstract]   [Full Text] [Related]  

  • 39. Urinary stone composition in Israel: current status and variation with age and sex--a bicenter study.
    Usman KD; Golan S; Abdin T; Livne PM; Pode D; Duvdevani M; Lifshitz D
    J Endourol; 2013 Dec; 27(12):1539-42. PubMed ID: 24266775
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fluoride concentrations in a collection of urinary calculi.
    Wandt MA; Rodgers AL
    J Urol; 1987 Sep; 138(3):644-7. PubMed ID: 3625873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.